Physician profile
Danielle M Barrow
NPI 1811930290
$1,028.19
in general payments reported to CMS, 2019-2025
13 companies · $441 in 2025
The $441 reported for 2025 was more than what 77% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $54.83 · 2020: $11.67 · 2022: $46.65 · 2023: $194 · 2024: $280 · 2025: $441.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $731 · Education: $184.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $731.04 |
| Education | $184.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $321.64 | 2023-2025 | Veozah |
| Organon LLC | $152.20 | 2022-2025 | Nexplanon, Nuvaring |
| Access Pro Medical, LLC | $131.58 | 2025 | Matriderm |
| Sage Therapeutics, LLC | $129.40 | 2025 | Zurzuvae |
| Exeltis, USA INC. | $110.65 | 2022-2025 | Slynd |
| Pfizer INC. | $63.06 | 2019-2024 | |
| Coopersurgical, INC. | $32.60 | 2025 | Paragard T 380a |
| Merck Sharp & Dohme LLC | $17.77 | 2025 | Gardasil 9 |
| Millicent US INC | $16.15 | 2025 | Femlyv |
| Abbvie INC. | $14.13 | 2019 | |
| Daiichi Sankyo INC. | $14.04 | 2019 | |
| Allergan, INC. | $13.30 | 2019 | |
| Lupin INC. | $11.67 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danielle Barrow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.